Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRIT Capital Partners Regulatory News (RCP)

Share Price Information for RIT Capital Partners (RCP)

Share Price is delayed by 15 minutes
Get Live Data
2,315.00    -5.00 (-0.22%)
Bid:
2,310.00
Ask:
2,320.00
Spread: 10.00 (0.433%)
Market Cap: £3.14b
RCP Live PriceLast checked at - London Stock Exchange

Intraday RIT Capital Partners Share Chart

Net Asset Value(s)

14 Oct 2022 07:00

RNS Number : 8548C
RIT Capital Partners PLC
14 October 2022
 

RIT CAPITAL PARTNERS PLC (LEI: P31Q1NLTW35JJGHA4667)

14 October 2022

 

30 September 2022 Net Asset Value and Commentary

The unaudited diluted net asset value of RIT Capital Partners plc as at 30 September 2022 (with debt at fair value) was 2,464p per £1 ordinary share (31 August 2022: 2,523p).

In light of the extraordinary market conditions experienced during late September, we felt it would be helpful for shareholders if we provided some more colour on the behaviour of our portfolio during times like these, as well as putting it into the context of our long-term objectives.

September saw equity markets fall sharply. The FTSE 250 lost -9.7%, the S&P 500 -9.2% and our own reference index, the MSCI All Countries World Index (50% Sterling) was down -7.1%. The exceptional volatility was not limited to equity markets, with all asset classes experiencing wide swings notably across currencies, bond markets and commodities. Against this most challenging backdrop, our NAV total return over the month was a decline of -2.3%. This outperformance reflected in particular:

· Our cautious positioning, with historically low levels of quoted equity exposure, helped to protect us from the brunt of the stock market falls;

· Positive contribution from our currency positioning, with around half our portfolio held outside of Sterling benefiting the NAV as Sterling weakened; and

· Some modest give back of the exceptional gains from our private investments over recent years. 

Our year-to-date NAV total return therefore shows a decline of -11.2% against the ACWI which lost -16.0%, with the outperformance reflecting broadly the same drivers as above. With a corporate objective focused on the long-term, our three-year performance of 31.9% compares favourably with the ACWI of 17.9% as does our five-year performance of 47.9% compared to 37.1% for global equities. This performance also exhibited lower risk, whether measured by volatility or the size of any drawdowns.

Our private investments have been a key source of returns over RIT's history and in particular during recent years. While we have seen some value compression this year, underlying portfolio companies continue to perform well and we remain confident in their ability to generate future NAV performance. Our direct private investments are valued on a six-monthly cycle by our independent Valuation Committee, and the private funds report quarterly fair values, on a lagged basis as is standard for this industry. By the end of September, the vast majority of our funds (around 99%) were valued at 30 June quarterly valuations. 

As shareholders are aware, the nature and composition of our investment portfolio enables us to produce monthly rather than daily NAVs. At times of significant market stress, the wider market conditions can dominate such that our share price moves in sync with broad equity markets, irrespective of our underlying NAV. This may lead to a widening of the discount. In these circumstances, we have continued our approach of seeking to minimise the impact on shareholders by buying back shares accretively. During September we acquired some 280,000 shares at a cost of around £6.1m, increasing the NAV per share. 

Shareholders will also be aware that our share price became ex-dividend on 6 October and we will pay our second interim dividend of 18.5p per share on 28 October. This will provide shareholders with a total dividend of 37p for 2022, 5.0% above 2021.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVEXLFFLBLEFBK
Date   Source Headline
3rd Jun 201610:24 amRNSForm 8.5 (EPT/RI)
3rd Jun 201610:23 amRNSForm 8.5 (EPT/RI)
2nd Jun 20163:27 pmRNSForm 8.3 - RIT Capital Partners Plc
2nd Jun 20163:27 pmRNSForm 8.3 - RIT Capital Partners Plc
2nd Jun 20163:12 pmRNSForm 8.3 - [RIT Capital Partners plc]
2nd Jun 201611:45 amRNSForm 8.5 (EPT/RI)
2nd Jun 201611:42 amRNSForm 8.5 (EPT/RI)
2nd Jun 201611:23 amRNSForm 8.3 - RIT Capital Partners Plc
2nd Jun 201610:30 amRNSForm 8.5 (EPT/RI) - RIT Capital Partners PLC
1st Jun 20163:40 pmRNSForm 8.3 - [RIT Capital Partners plc]
1st Jun 20163:32 pmRNSForm 8.3 - RIT Capital Partners Plc
1st Jun 20163:20 pmRNSForm 8.3 - RIT Capital Partners PLC
1st Jun 20163:00 pmRNSForm 8.3 - RIT Capital Partners Plc
1st Jun 20161:34 pmRNSForm 8.3 - RIT Capital Partners Plc
1st Jun 20161:01 pmRNSForm 8.3 - RIT Capital Partners plc
1st Jun 201611:46 amRNSForm 8.3 - RIT Capital Partners PLC
1st Jun 201611:11 amRNSForm 8.5 (EPT/RI)
1st Jun 201611:08 amRNSForm 8.5 (EPT/RI)
1st Jun 201610:45 amRNSForm 8.5 (EPT/RI) - RIT Capital Partners PLC
31st May 20161:17 pmRNSRule 2.10 Announcement
31st May 20161:00 pmRNSRule 2.0 Announcement
31st May 20167:01 amRNSResponse to Press Speculation
20th May 20164:12 pmRNSDirector/PDMR Shareholding
12th May 20167:00 amRNSNet Asset Value(s)
21st Apr 201612:17 pmRNSResult of AGM
14th Apr 20167:00 amRNSNet Asset Value(s)
24th Mar 20164:38 pmRNSDirector/PDMR Shareholding
11th Mar 20167:00 amRNSNet Asset Value(s)
8th Mar 20167:00 amRNSDirector/PDMR Shareholding
3rd Mar 20167:00 amRNSDirector/PDMR Shareholding
1st Mar 20167:00 amRNSFinal Results, Dividend and Directorate
16th Feb 20167:00 amRNSNet Asset Value(s)
3rd Feb 20167:00 amRNSNet Asset Value(s)
31st Dec 201512:24 pmRNSDirector/PDMR Shareholding
14th Dec 20157:00 amRNSNet Asset Value(s)
4th Dec 20152:37 pmRNSDirector/PDMR Shareholding
12th Nov 20157:00 amRNSNet Asset Value(s)
16th Oct 20157:00 amRNSComposition of Board Committee
13th Oct 20157:00 amRNSNet Asset Value(s)
1st Oct 20157:00 amRNSDirectorate Change
10th Sep 20157:00 amRNSNet Asset Value(s)
14th Aug 20157:00 amRNSNet Asset Value(s)
11th Aug 20157:00 amRNSHalf Yearly Report and Dividend
24th Jul 20157:00 amRNSNet Asset Value(s)
16th Jun 20155:49 pmRNSDirector/PDMR Shareholding
11th Jun 20157:00 amRNSNet Asset Value(s)
9th Jun 20153:58 pmRNSHolding(s) in Company
14th May 20157:00 amRNSNet Asset Value(s)
14th May 20157:00 amRNSFixed rate note borrowing
30th Apr 20152:09 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.